The Research Institute of Molecular Pathology (IMP) is a leading basic research institute. Its 15 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP is the ideal environment for curiosity-driven biomedical research. As part of Vienna BioCenter, the IMP is embedded in one of Europe’s biggest life science hubs with 1,800 employees at 4 research institutes, 24 biotech companies and 3 universities.
Learn more: www.imp.ac.at/ - www.viennabiocenter.org/
Shared 1 week ago
83 views
Shared 2 weeks ago
229 views
Shared 3 weeks ago
116 views
Shared 4 weeks ago
94 views
Shared 4 weeks ago
98 views
Shared 1 month ago
145 views
Shared 1 month ago
77 views
Shared 3 months ago
103 views
Shared 4 months ago
1.7K views
Shared 5 months ago
375 views
Shared 5 months ago
426 views
Shared 5 months ago
107 views
Shared 5 months ago
155 views
Shared 5 months ago
143 views
Shared 5 months ago
208 views
Shared 5 months ago
278 views
Shared 8 months ago
48 views
Shared 8 months ago
45 views
Shared 8 months ago
30 views
Shared 9 months ago
240 views
Shared 9 months ago
172 views
Shared 10 months ago
401 views
Shared 10 months ago
212 views
Shared 10 months ago
380 views
Shared 11 months ago
435 views
Shared 11 months ago
376 views
Shared 1 year ago
960 views
Shared 1 year ago
796 views
Shared 1 year ago
872 views
Shared 1 year ago
595 views
Shared 1 year ago
1.1K views
Shared 1 year ago
1.2K views
Shared 1 year ago
1.3K views
Shared 1 year ago
1.2K views
Shared 1 year ago
1.6K views
Shared 1 year ago
464 views
Shared 2 years ago
362 views
Shared 2 years ago
625 views
Shared 2 years ago
304 views
Shared 2 years ago
632 views
Shared 2 years ago
540 views
Shared 2 years ago
840 views
Shared 2 years ago
603 views
Shared 2 years ago
259 views
Shared 2 years ago
415 views
Shared 2 years ago
1.2K views
Shared 2 years ago
1.2K views
Shared 2 years ago
541 views
Shared 2 years ago
1K views
Shared 2 years ago
866 views
Shared 2 years ago
773 views
Shared 3 years ago
834 views
Shared 3 years ago
339 views
Shared 3 years ago
865 views